(NaturalNews) This bipartisan Congressional committee currently investigating the secrets dealings between the Obama administration and Big Pharma before passage of the massive medical overhaul is set to release pertinent new details as to what these dealings entailed. In a recent memorandum, the committee unveils the names of a few of the key figures involved with these types of secret negotiations, and promises release a even more shocking details inside coming weeks.
Addressed specifically for the Republican members of the Strength and Commerce Committee, the memo explains a bit more about how the Pharmaceutical Suppliers of America (PhRMA), a powerful lobbying group that represents the particular drug and biotechnology industries, colluded with the federal government to make the terms associated with Obamacare as favorable to drug companies as it can be. Both the federal government and PhRMA secretly opted for abide by certain undisclosed commitments to one another included in the passage of the bill, information of which largely remain invisible from public view.
"In the coming weeks the Committee intends to exhibit what the White House agreed to do in its deal with the pharmaceutical industry and what sort of full details of this agreement were kept from both public and the House associated with Representatives, " wrote members on the town Energy and Commerce Subcommittee on Oversight and Investigations in their memo.
"The investigation has determined that this White House, primarily through Place of work of Health Reform Director Nancy Ann DeParle in addition to (Jim) Messina, with involvement via Chief of Staff Rahm Emmanuel, was actively engaged in these negotiations as the role of Congress was limited. "A private email routed by Jim Messina, for occasion, then Deputy Chief of Staff for Operations for the White House, to a PhRMA lobbyist back on January 15, 2010, exposed the truth that the White House had made a secret "deal" with this group. In Messina's own words, PhRMA had apparently done an issue that "wasn't part of our cope, " which had upset the White House at the time.
Obama directly involved in PhRMA discussions, despite having told public Economic council chair was involved
While many people are aware of the fact that dealings were, in fact, made between the drug industry and the government within the terms of Obamacare, it is widely assumed that this U. S. Senate forged any agreement -- this is, naturally, what Obama had claimed at the time. But these new revelations expose the truth that key White House figures were actively associated with placating the demands of Big Pharma, albeit behind the views, while crafting the bill.
Former OHR Director Nancy Ann DeParle accepted in another uncovered email that this White House had deliberately excluded the home of Representatives in the discussions process. And many members associated with Congress, as we now learn, admittedly did not even understand what was in the final 2, 700-page bill because they did not get enable you to read it before it was quickly rushed through and approved
Reference: http://www.healthcoveragestocks.com
ไม่มีความคิดเห็น:
แสดงความคิดเห็น